Ensuring Access to Effective Patient Medication Information
Consumers and patients need information about their medications that is accurate, balanced and delivered in an easily understood format. Unfortunately, recent studies have shown that current systems for delivering prescriptions to consumers consistently fail to fulfill the need for pertinent details.
On October 12, the Engelberg Center for Health Care Reform at Brookings hosted a public forum to discuss strategies for ensuring that patients have access to effective patient medication information (PMI). Through a series of panel discussions, key stakeholders explored patients’ expectations for this information and how they access the details and warnings, along with feasible solutions for delivering higher-quality information to patients.
After each panel, speakers took audience questions.
Agenda
Welcome, Overview, Key Elements of Effective PMI
Mark B. McClellan
Former Brookings Expert
Director, Margolis Center for Health Policy - Duke University
Janet Woodcock
Director, Center for Drug Evaluation and Research - US Food and Drug Administration
9:25 a.m. -- Session I: FDA and Patient Medication Information – The Path Forward
Rachel Behrman
Director, Office of Medical Policy, Center for Drug Evaluation and Research
Amie O’Donoghue
Office of Medical Policy, Center for Drug Evaluation and Research, FDA
10:20 a.m. -- Session II: Patient Perspectives – Making PMI More Effective
Mark B. McClellan
Former Brookings Expert
Director, Margolis Center for Health Policy - Duke University
Doris Peter
Director, Health Ratings Center - Consumer Health Choices
Nancy Hughes
Assistant Vice President of Communications and Marketing, National Health Council
Vanessa Cajina
Statewide Policy Analyst, California Immigrant Policy Center
Lee Rucker
AARP Public Policy Institute, AARP
James Heywood
Co-Founder and Chairman, PatientsLikeMe
12:45 p.m. -- Session III: Effective PMI – The Roles of Manufacturers and PMI Vendors
Mark B. McClellan
Former Brookings Expert
Director, Margolis Center for Health Policy - Duke University
Tom Bizarro
Vice President, Health Policy and Industry Relations, First DataBank
Baxter Byerly
Catalina Health Resource
Marissa Craddock
Manager, Labeling, Advertising, and Promotional Materials, Roxane Laboratories, Inc.
Freda Lewis-Hall
Pfizer
Pamela Budny
Eli Lilly and Company
2:25 p.m. -- Session IV: Effective Distribution of PMI
S. Lawrence Kocot
Former Brookings Expert
Principal and National Leader, Center for Healthcare Regulatory Insight - KPMG
William Shrank
Harvard Medical School and Brigham & Women's Hospital
Kate Berry
Senior Vice President, Strategy and Innovation, Surescripts
Will Lockwood
Assistant to the Executive Director, American Society for Automation in Pharmacy
John Coster
Senior Vice President, Government Affairs, National Community Pharmacists Association
Russell Teagarden
Vice President, Clinical Practices & Therapeutics, Medco Health Solutions, Inc.
3:50 p.m. -- Recap and Closing Remarks
Rachel Behrman
Director, Office of Medical Policy, Center for Drug Evaluation and Research
More Information
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.